---
title: "Immunovant (IMVT.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/IMVT.US/norm.md"
symbol: "IMVT.US"
name: "Immunovant"
parent: "https://longbridge.com/zh-CN/quote/IMVT.US.md"
datetime: "2026-05-21T21:41:12.530Z"
locales:
  - [en](https://longbridge.com/en/quote/IMVT.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/IMVT.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/IMVT.US/norm.md)
---

# Immunovant (IMVT.US) — 财务报表

## 利润表 (USD)

| 指标 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.7258 | -0.6095 | -0.7285 | -0.7059 | -0.6384 |
| ROE | -64.33% | -58.78% | -89.70% | -73.32% | -80.33% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -147.86M | -110.64M | -126.50M | -120.61M | -106.45M |
| 营业利润 | -159.55M | -114.36M | -131.76M | -127.22M | -113.83M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 957.01M | 1.05B | 582.96M | 661.44M | 776.22M |
| 权益乘数 | 1.12 | 1.07 | 1.12 | 1.09 | 1.10 |
| 每股净资产 | 4.18 | 4.85 | 2.98 | 3.56 | 4.16 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 902.11M | 994.52M | 521.87M | 598.91M | 713.97M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 515000.00 | 531000.00 | 632000.00 | 737000.00 | 942000.00 |
| 净债务 | -902.04M | -994.52M | -521.87M | -598.91M | -713.87M |

## 现金流量表 (USD)

| 指标 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | - | -92.33M | -102.52M | -117.41M | -110.64M |
| 投资现金流 | - | - | - | - | -201000.00 |
| 融资现金流 | - | 564.60M | 24.59M | 2.92M | 450.61M |
| 自由现金流 | - | -52.40M | -57.53M | -75.83M | -75.00M |
| 现金流充裕率 | - | - | - | - | -55043.28% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | - | - | - | -201000.00 |